Integrin αvβ6–TGFβ–SOX4 Pathway Drives Immune Evasion in Triple-Negative Breast Cancer is a research paper published in Cancer Cell (2020). On theSindex it has a DataRank of 0. It has been cited 211 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: P30 CA006516
NCI NIH HHS
Grant: P50 CA168504
NCI NIH HHS
Grant: R01 CA251599
NCI NIH HHS
Grant: R01 CA238039
NCI NIH HHS
Grant: T32 CA207021
NIGMS NIH HHS
Grant: T32 GM007753
NCI NIH HHS
Grant: P01 CA163222
National Institutes of Health
Grant: 3P30CA006516-41S6
CANCER CENTER SUPPORT GRANT
National Institutes of Health
Grant: 5T32CA207021-04
Cancer Immunology Training Grant
National Institutes of Health
Grant: 5P50CA168504-03
Overcoming Resistance to Standard HER2-Directed Therapies for Breast Cancer
National Institutes of Health
Grant: 5R01CA251599-02
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
National Institutes of Health
Grant: 5P01CA163222-08
Targetable epigenetic and transcriptional mechanisms in melanoma that shape the microenvironment
American Association for Cancer Research
National Institutes of Health
Cancer Research Institute
FWCI
12.32
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals